TERM ID="NYU_TERM_1" STRING="ALLHAT" FREQUENCY=9 START=312 END=318 LEMMA="ALLHAT" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_2" STRING="ALLHAT" FREQUENCY=9 START=761 END=767 LEMMA="ALLHAT" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_3" STRING="ALLHAT" FREQUENCY=9 START=1231 END=1237 LEMMA="ALLHAT" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_4" STRING="ALLHAT" FREQUENCY=9 START=11073 END=11079 LEMMA="ALLHAT" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_5" STRING="ALLHAT" FREQUENCY=9 START=11746 END=11752 LEMMA="ALLHAT" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_6" STRING="ALLHAT" FREQUENCY=9 START=12291 END=12297 LEMMA="ALLHAT" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_7" STRING="ALLHAT" FREQUENCY=9 START=14089 END=14095 LEMMA="ALLHAT" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_8" STRING="ALLHAT" FREQUENCY=9 START=14774 END=14780 LEMMA="ALLHAT" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_9" STRING="ALLHAT" FREQUENCY=9 START=17551 END=17557 LEMMA="ALLHAT" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_10" STRING="ALLHAT participants" FREQUENCY=1 START=13557 END=13576 LEMMA="ALLHAT PARTICIPANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="ALLHAT population" FREQUENCY=1 START=13760 END=13787 LEMMA="ALLHAT POPULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="ALLHAT trial" FREQUENCY=2 START=14175 END=14187 LEMMA="ALLHAT TRIAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_13" STRING="ALLHAT trial" FREQUENCY=2 START=15792 END=15804 LEMMA="ALLHAT TRIAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_14" STRING="Alpha-1 antagonists" FREQUENCY=1 START=3311 END=3330 LEMMA="ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="Antihypertensive" FREQUENCY=1 START=71 END=87 LEMMA="ANTIHYPERTENSIVE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_16" STRING="Antihypertensive agents" FREQUENCY=1 START=5402 END=5425 LEMMA="ANTIHYPERTENSIVE AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="BPH" FREQUENCY=2 START=3448 END=3451 LEMMA="BPH" LEMMA_FREQUENCY=2 HEAD_TERM="BPH" HEAD_LEMMA="BPH" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_18" STRING="BPH" FREQUENCY=2 START=3886 END=3889 LEMMA="BPH" LEMMA_FREQUENCY=2 HEAD_TERM="BPH" HEAD_LEMMA="BPH" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_19" STRING="CHD" FREQUENCY=1 START=12035 END=12038 LEMMA="CORONARY HEART DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="CHF" FREQUENCY=8 START=748 END=751 LEMMA="CHF" LEMMA_FREQUENCY=8
TERM ID="NYU_TERM_21" STRING="CHF" FREQUENCY=8 START=877 END=880 LEMMA="CHF" LEMMA_FREQUENCY=8
TERM ID="NYU_TERM_22" STRING="CHF" FREQUENCY=8 START=13380 END=13383 LEMMA="CHF" LEMMA_FREQUENCY=8
TERM ID="NYU_TERM_23" STRING="CHF" FREQUENCY=8 START=13550 END=13553 LEMMA="CHF" LEMMA_FREQUENCY=8
TERM ID="NYU_TERM_24" STRING="CHF" FREQUENCY=8 START=15306 END=15309 LEMMA="CHF" LEMMA_FREQUENCY=8
TERM ID="NYU_TERM_25" STRING="CHF" FREQUENCY=8 START=15781 END=15784 LEMMA="CHF" LEMMA_FREQUENCY=8
TERM ID="NYU_TERM_26" STRING="CHF" FREQUENCY=8 START=16317 END=16320 LEMMA="CHF" LEMMA_FREQUENCY=8
TERM ID="NYU_TERM_27" STRING="CHF" FREQUENCY=8 START=17158 END=17161 LEMMA="CHF" LEMMA_FREQUENCY=8
TERM ID="NYU_TERM_28" STRING="Cellular Effects" FREQUENCY=1 START=8319 END=8335 LEMMA="CELLULAR EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="Cellular Effects Physiologic studies" FREQUENCY=1 START=8319 END=8365 LEMMA="PHYSIOLOGIC STUDY CELLULAR EFFECT" LEMMA_FREQUENCY=1 HEAD_TERM="Physiologic studies" HEAD_LEMMA="PHYSIOLOGIC STUDY"
TERM ID="NYU_TERM_30" STRING="Chronic volume loading" FREQUENCY=1 START=17295 END=17317 LEMMA="CHRONIC VOLUME LOADING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="Clinical Trial Data" FREQUENCY=1 START=10814 END=10833 LEMMA="CLINICAL TRIAL DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="Comparing data" FREQUENCY=1 START=14421 END=14435 LEMMA="COMPARING DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="Competing Interests" FREQUENCY=1 START=17789 END=17808 LEMMA="COMPETING INTEREST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="Competing Interests Dr" FREQUENCY=1 START=17789 END=17819 LEMMA="DR COMPETING INTEREST" LEMMA_FREQUENCY=1 HEAD_TERM="Dr" HEAD_LEMMA="DR"
TERM ID="NYU_TERM_35" STRING="Differentiation" FREQUENCY=1 START=16925 END=16940 LEMMA="DIFFERENTIATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="Doxazosin" FREQUENCY=1 START=7374 END=7383 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_37" STRING="Dr" FREQUENCY=1 START=17817 END=17819 LEMMA="DR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="ECFV" FREQUENCY=1 START=4384 END=4388 LEMMA="ECFV" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="Elevated plasma norepinephrine levels" FREQUENCY=1 START=9232 END=9279 LEMMA="ELEVATED PLASMA NOREPINEPHRINE LEVEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="Endothelin-1" FREQUENCY=1 START=10003 END=10015 LEMMA="ENDOTHELIN-1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_41" STRING="English-language papers" FREQUENCY=1 START=1437 END=1460 LEMMA="ENGLISH-LANGUAGE PAPER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="Epidemiologic Research" FREQUENCY=1 START=17963 END=17985 LEMMA="EPIDEMIOLOGIC RESEARCH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="Epidemiological" FREQUENCY=1 START=10794 END=10809 LEMMA="EPIDEMIOLOGICAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="Fluid Status" FREQUENCY=1 START=3937 END=3949 LEMMA="FLUID STATUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="Fluid Status Peripheral alpha-1 antagonists" FREQUENCY=1 START=3937 END=3990 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST FLUID STATUS" LEMMA_FREQUENCY=1 HEAD_TERM="Peripheral alpha-1 antagonists" HEAD_LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST"
TERM ID="NYU_TERM_46" STRING="Framingham Heart Study logistic regression coefficients" FREQUENCY=1 START=14935 END=14990 LEMMA="FRAMINGHAM HEART STUDY LOGISTIC REGRESSION COEFFICIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="Heart Attack Trial" FREQUENCY=1 START=136 END=154 LEMMA="HEART ATTACK TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_48" STRING="JNC VI" FREQUENCY=1 START=3023 END=3029 LEMMA="JNC VI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="Kaplan-Meier curves" FREQUENCY=1 START=15878 END=15897 LEMMA="KAPLAN-MEIER CURVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="Lipid-Lowering Treatment" FREQUENCY=1 START=100 END=124 LEMMA="LIPID-LOWERING TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_51" STRING="Lund-Johansen" FREQUENCY=1 START=7473 END=7486 LEMMA="LUND-JOHANSEN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="Medline" FREQUENCY=2 START=1372 END=1379 LEMMA="MEDLINE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_53" STRING="Medline" FREQUENCY=2 START=1710 END=1717 LEMMA="MEDLINE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_54" STRING="Merck/SER Clinical Epidemiology Fellow" FREQUENCY=1 START=17833 END=17871 LEMMA="MERCK/SER CLINICAL EPIDEMIOLOGY FELLOW" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_55" STRING="Mild Hypertension Study" FREQUENCY=1 START=7922 END=7955 LEMMA="MILD HYPERTENSION STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="NJ" FREQUENCY=1 START=17931 END=17933 LEMMA="NJ" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="National Ambulatory Medical Care Survey" FREQUENCY=1 START=3495 END=3544 LEMMA="NATIONAL AMBULATORY MEDICAL CARE SURVEY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="National Committee" FREQUENCY=1 START=2908 END=2926 LEMMA="NATIONAL COMMITTEE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_59" STRING="Neurohormonal" FREQUENCY=1 START=8301 END=8314 LEMMA="NEUROHORMONAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_60" STRING="Peripheral alpha-1 antagonists" FREQUENCY=3 START=3960 END=3990 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_61" STRING="Peripheral alpha-1 antagonists" FREQUENCY=3 START=8570 END=8610 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_62" STRING="Peripheral alpha-1 antagonists" FREQUENCY=3 START=15921 END=15951 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_63" STRING="Physiologic studies" FREQUENCY=1 START=8346 END=8365 LEMMA="PHYSIOLOGIC STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_64" STRING="Prostatism Evidence" FREQUENCY=1 START=2473 END=2502 LEMMA="PROSTATISM EVIDENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_65" STRING="Psaty" FREQUENCY=1 START=17821 END=17826 LEMMA="PSATY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_66" STRING="RR" FREQUENCY=3 START=12208 END=12210 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_67" STRING="RR" FREQUENCY=3 START=12257 END=12259 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_68" STRING="RR" FREQUENCY=3 START=13329 END=13331 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_69" STRING="Rahway" FREQUENCY=1 START=17923 END=17929 LEMMA="RAHWAY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_70" STRING="SHEP participants" FREQUENCY=1 START=13387 END=13414 LEMMA="SHEP PARTICIPANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_71" STRING="SHEP trial" FREQUENCY=3 START=12536 END=12546 LEMMA="SHEP TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_72" STRING="SHEP trial" FREQUENCY=3 START=12810 END=12820 LEMMA="SHEP TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_73" STRING="SHEP trial" FREQUENCY=3 START=13979 END=13989 LEMMA="SHEP TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_74" STRING="Subjects" FREQUENCY=1 START=12997 END=13005 LEMMA="SUBJECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_75" STRING="VA Cooperative Study" FREQUENCY=1 START=5378 END=5398 LEMMA="VA COOPERATIVE STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_76" STRING="Withdrawal" FREQUENCY=1 START=7268 END=7278 LEMMA="WITHDRAWAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_77" STRING="Wyeth" FREQUENCY=1 START=18084 END=18089 LEMMA="WYETH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_78" STRING="absolute risk reduction" FREQUENCY=1 START=16747 END=16778 LEMMA="ABSOLUTE RISK REDUCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_79" STRING="absolute risk reduction for clinical heart failure" FREQUENCY=1 START=16747 END=16805 LEMMA="CLINICAL HEART FAILURE ABSOLUTE RISK REDUCTION" LEMMA_FREQUENCY=1 HEAD_TERM="absolute risk reduction" HEAD_LEMMA="ABSOLUTE RISK REDUCTION"
TERM ID="NYU_TERM_80" STRING="active-control trial" FREQUENCY=1 START=774 END=794 LEMMA="ACTIVE-CONTROL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_81" STRING="acute changes" FREQUENCY=1 START=5234 END=5257 LEMMA="ACUTE CHANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_82" STRING="acute renal effect" FREQUENCY=1 START=4999 END=5017 LEMMA="ACUTE RENAL EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_83" STRING="acute renal effect of prazosin" FREQUENCY=1 START=4999 END=5029 LEMMA="PRAZOSIN ACUTE RENAL EFFECT" LEMMA_FREQUENCY=1 HEAD_TERM="acute renal effect" HEAD_LEMMA="ACUTE RENAL EFFECT"
TERM ID="NYU_TERM_84" STRING="addition" FREQUENCY=1 START=9551 END=9559 LEMMA="ADDITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_85" STRING="adrenergic alpha-antagonists" FREQUENCY=1 START=1830 END=1858 LEMMA="ADRENERGIC ALPHA-ANTAGONIST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_86" STRING="alpha blocker" FREQUENCY=1 START=1865 END=1886 LEMMA="ALPHA BLOCKER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_87" STRING="alpha-1" FREQUENCY=1 START=9571 END=9578 LEMMA="ALPHA-1" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_88" STRING="alpha-1 antagonists" FREQUENCY=1 START=2517 END=2536 LEMMA="ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_89" STRING="alpha-1 cardiac receptors" FREQUENCY=1 START=9571 END=9596 LEMMA="CARDIAC RECEPTOR ALPHA-1" LEMMA_FREQUENCY=1 HEAD_TERM="cardiac receptors" HEAD_LEMMA="CARDIAC RECEPTOR"
TERM ID="NYU_TERM_90" STRING="alpha-1 receptor inhibition" FREQUENCY=1 START=9779 END=9806 LEMMA="ALPHA-1 RECEPTOR INHIBITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_91" STRING="antihypertensive effects" FREQUENCY=1 START=14708 END=14732 LEMMA="ANTIHYPERTENSIVE EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_92" STRING="antihypertensive efficacy" FREQUENCY=1 START=5629 END=5654 LEMMA="ANTIHYPERTENSIVE EFFICACY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_93" STRING="antihypertensive therapy" FREQUENCY=1 START=15504 END=15528 LEMMA="ANTIHYPERTENSIVE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_94" STRING="antihypertensives" FREQUENCY=1 START=14647 END=14664 LEMMA="ANTIHYPERTENSIVE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_95" STRING="apoptosis" FREQUENCY=2 START=9477 END=9486 LEMMA="APOPTOSI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_96" STRING="apoptosis" FREQUENCY=2 START=9839 END=9848 LEMMA="APOPTOSI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_97" STRING="assessed differences" FREQUENCY=1 START=11103 END=11123 LEMMA="ASSESSED DIFFERENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_98" STRING="atenolol" FREQUENCY=2 START=6412 END=6420 LEMMA="ATENOLOL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_99" STRING="atenolol" FREQUENCY=2 START=10326 END=10334 LEMMA="ATENOLOL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_100" STRING="background physiologic literature" FREQUENCY=1 START=1550 END=1591 LEMMA="BACKGROUND PHYSIOLOGIC LITERATURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_101" STRING="baseline" FREQUENCY=2 START=6660 END=6668 LEMMA="BASELINE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_102" STRING="baseline" FREQUENCY=2 START=7005 END=7013 LEMMA="BASELINE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_103" STRING="benign prostatic hypertrophy" FREQUENCY=1 START=2791 END=2829 LEMMA="BENIGN PROSTATIC HYPERTROPHY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_104" STRING="beta blockers" FREQUENCY=1 START=3178 END=3191 LEMMA="BETA BLOCKER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_105" STRING="beta receptor stimulation" FREQUENCY=1 START=9729 END=9764 LEMMA="BETA RECEPTOR STIMULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_106" STRING="beta receptors" FREQUENCY=1 START=9524 END=9538 LEMMA="BETA RECEPTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_107" STRING="beta-blockers" FREQUENCY=1 START=17661 END=17674 LEMMA="BETA-BLOCKER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_108" STRING="bibliographic searches" FREQUENCY=1 START=2368 END=2398 LEMMA="BIBLIOGRAPHIC SEARCH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_109" STRING="blood-pressure reduction" FREQUENCY=1 START=11344 END=11368 LEMMA="BLOOD-PRESSURE REDUCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_110" STRING="captopril" FREQUENCY=2 START=5514 END=5523 LEMMA="CAPTOPRIL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_111" STRING="captopril" FREQUENCY=2 START=6394 END=6403 LEMMA="CAPTOPRIL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_112" STRING="cardiac damage" FREQUENCY=1 START=10550 END=10564 LEMMA="CARDIAC DAMAGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_113" STRING="cardiac receptors" FREQUENCY=1 START=9579 END=9596 LEMMA="CARDIAC RECEPTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_114" STRING="cardiotoxic" FREQUENCY=1 START=9211 END=9222 LEMMA="CARDIOTOXIC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_115" STRING="cardiovascular complications" FREQUENCY=1 START=16605 END=16633 LEMMA="CARDIOVASCULAR COMPLICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_116" STRING="cardiovascular disease" FREQUENCY=1 START=9912 END=9944 LEMMA="CARDIOVASCULAR DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_117" STRING="cardiovascular endpoints" FREQUENCY=4 START=1524 END=1548 LEMMA="CARDIOVASCULAR ENDPOINT" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_118" STRING="cardiovascular endpoints" FREQUENCY=4 START=1684 END=1708 LEMMA="CARDIOVASCULAR ENDPOINT" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_119" STRING="cardiovascular endpoints" FREQUENCY=4 START=11127 END=11161 LEMMA="CARDIOVASCULAR ENDPOINT" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_120" STRING="cardiovascular endpoints" FREQUENCY=4 START=11579 END=11613 LEMMA="CARDIOVASCULAR ENDPOINT" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_121" STRING="cardiovascular events" FREQUENCY=1 START=16823 END=16844 LEMMA="CARDIOVASCULAR EVENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_122" STRING="cardiovascular outcomes" FREQUENCY=1 START=12397 END=12420 LEMMA="CARDIOVASCULAR OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_123" STRING="case control" FREQUENCY=1 START=11486 END=11498 LEMMA="CASE CONTROL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_124" STRING="catecholamine levels" FREQUENCY=1 START=9186 END=9206 LEMMA="CATECHOLAMINE LEVEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_125" STRING="cellular injury" FREQUENCY=1 START=10380 END=10395 LEMMA="CELLULAR INJURY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_126" STRING="cellular repair mechanisms" FREQUENCY=1 START=10495 END=10521 LEMMA="CELLULAR REPAIR MECHANISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_127" STRING="chlorthalidone" FREQUENCY=4 START=956 END=970 LEMMA="CHLORTHALIDONE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_128" STRING="chlorthalidone" FREQUENCY=4 START=12601 END=12615 LEMMA="CHLORTHALIDONE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_129" STRING="chlorthalidone" FREQUENCY=4 START=14902 END=14916 LEMMA="CHLORTHALIDONE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_130" STRING="chlorthalidone" FREQUENCY=4 START=16574 END=16588 LEMMA="CHLORTHALIDONE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_131" STRING="chlorthalidone arm" FREQUENCY=2 START=460 END=478 LEMMA="CHLORTHALIDONE ARM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_132" STRING="chlorthalidone arm" FREQUENCY=2 START=11946 END=11964 LEMMA="CHLORTHALIDONE ARM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_133" STRING="cholesterol" FREQUENCY=1 START=11384 END=11395 LEMMA="CHOLESTEROL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_134" STRING="cholesterol levels" FREQUENCY=1 START=1159 END=1177 LEMMA="CHOLESTEROL LEVEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_135" STRING="chronic congestive heart failure" FREQUENCY=1 START=9036 END=9068 LEMMA="CHRONIC CONGESTIVE HEART FAILURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_136" STRING="chronic sodium homeostasis" FREQUENCY=1 START=5275 END=5301 LEMMA="CHRONIC SODIUM HOMEOSTASI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_137" STRING="chronic therapy" FREQUENCY=2 START=4582 END=4607 LEMMA="CHRONIC THERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_138" STRING="chronic therapy" FREQUENCY=2 START=16000 END=16015 LEMMA="CHRONIC THERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_139" STRING="clinical heart failure" FREQUENCY=1 START=16783 END=16805 LEMMA="CLINICAL HEART FAILURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_140" STRING="clinical heart failure events" FREQUENCY=1 START=13817 END=13856 LEMMA="CLINICAL HEART FAILURE EVENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_141" STRING="clinical presentation" FREQUENCY=1 START=15614 END=15643 LEMMA="CLINICAL PRESENTATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_142" STRING="clinical presentation of heart failure" FREQUENCY=1 START=15614 END=15660 LEMMA="HEART FAILURE CLINICAL PRESENTATION" LEMMA_FREQUENCY=1 HEAD_TERM="clinical presentation" HEAD_LEMMA="CLINICAL PRESENTATION"
TERM ID="NYU_TERM_143" STRING="clinical trials" FREQUENCY=1 START=1920 END=1935 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_144" STRING="clonidine" FREQUENCY=2 START=5525 END=5534 LEMMA="CLONIDINE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_145" STRING="clonidine" FREQUENCY=2 START=6311 END=6320 LEMMA="CLONIDINE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_146" STRING="cohort" FREQUENCY=1 START=11500 END=11506 LEMMA="COHORT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_147" STRING="comparative trial" FREQUENCY=1 START=12313 END=12330 LEMMA="COMPARATIVE TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_148" STRING="comparing atenolol" FREQUENCY=1 START=5484 END=5512 LEMMA="COMPARING ATENOLOL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_149" STRING="concentration" FREQUENCY=1 START=9668 END=9681 LEMMA="CONCENTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_150" STRING="concentration of norepinephrine" FREQUENCY=1 START=9668 END=9709 LEMMA="NOREPINEPHRINE CONCENTRATION" LEMMA_FREQUENCY=1 HEAD_TERM="concentration" HEAD_LEMMA="CONCENTRATION"
TERM ID="NYU_TERM_151" STRING="concomitant alpha-1 blockade" FREQUENCY=1 START=9402 END=9430 LEMMA="CONCOMITANT ALPHA-1 BLOCKADE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_152" STRING="congestive heart failure" FREQUENCY=1 START=384 END=408 LEMMA="CONGESTIVE HEART FAILURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_153" STRING="controlled trial" FREQUENCY=1 START=5467 END=5483 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_154" STRING="controlled trial comparing atenolol" FREQUENCY=1 START=5467 END=5512 LEMMA="COMPARING ATENOLOL CONTROLLED TRIAL" LEMMA_FREQUENCY=1 HEAD_TERM="comparing atenolol" HEAD_LEMMA="COMPARING ATENOLOL"
TERM ID="NYU_TERM_155" STRING="controlled trials" FREQUENCY=2 START=7635 END=7652 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_156" STRING="controlled trials" FREQUENCY=2 START=10928 END=10945 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_157" STRING="demographic" FREQUENCY=1 START=12742 END=12753 LEMMA="DEMOGRAPHIC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_158" STRING="diastolic blood pressure" FREQUENCY=1 START=12950 END=12974 LEMMA="DIASTOLIC BLOOD PRESSURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_159" STRING="diastolic hypertension" FREQUENCY=1 START=5691 END=5713 LEMMA="DIASTOLIC HYPERTENSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_160" STRING="diltiazem" FREQUENCY=1 START=5536 END=5545 LEMMA="DILTIAZEM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_161" STRING="diuretics" FREQUENCY=3 START=13428 END=13437 LEMMA="DIURETIC" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_162" STRING="diuretics" FREQUENCY=3 START=13600 END=13609 LEMMA="DIURETIC" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_163" STRING="diuretics" FREQUENCY=3 START=17001 END=17010 LEMMA="DIURETIC" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_164" STRING="diverse patient populations" FREQUENCY=1 START=8826 END=8863 LEMMA="DIVERSE PATIENT POPULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_165" STRING="dose diuretics" FREQUENCY=1 START=14258 END=14272 LEMMA="DOSE DIURETIC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_166" STRING="double-blind" FREQUENCY=1 START=5442 END=5454 LEMMA="DOUBLE-BLIND" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_167" STRING="doxazosin" FREQUENCY=13 START=644 END=653 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_168" STRING="doxazosin" FREQUENCY=13 START=914 END=923 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_169" STRING="doxazosin" FREQUENCY=13 START=1290 END=1299 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_170" STRING="doxazosin" FREQUENCY=13 START=1784 END=1793 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_171" STRING="doxazosin" FREQUENCY=13 START=7823 END=7832 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_172" STRING="doxazosin" FREQUENCY=13 START=10167 END=10176 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_173" STRING="doxazosin" FREQUENCY=13 START=12345 END=12354 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_174" STRING="doxazosin" FREQUENCY=13 START=12484 END=12493 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_175" STRING="doxazosin" FREQUENCY=13 START=13614 END=13623 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_176" STRING="doxazosin" FREQUENCY=13 START=13905 END=13914 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_177" STRING="doxazosin" FREQUENCY=13 START=14761 END=14770 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_178" STRING="doxazosin" FREQUENCY=13 START=15425 END=15434 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_179" STRING="doxazosin" FREQUENCY=13 START=16533 END=16542 LEMMA="DOXAZOSIN" LEMMA_FREQUENCY=14
TERM ID="NYU_TERM_180" STRING="doxazosin arm" FREQUENCY=2 START=295 END=308 LEMMA="DOXAZOSIN ARM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_181" STRING="doxazosin arm" FREQUENCY=2 START=11877 END=11890 LEMMA="DOXAZOSIN ARM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_182" STRING="doxazosin arm of ALLHAT" FREQUENCY=1 START=295 END=318 LEMMA="ALLHAT DOXAZOSIN ARM" LEMMA_FREQUENCY=1 HEAD_TERM="doxazosin arm" HEAD_LEMMA="DOXAZOSIN ARM"
TERM ID="NYU_TERM_183" STRING="doxazosin arm termination" FREQUENCY=1 START=14060 END=14085 LEMMA="DOXAZOSIN ARM TERMINATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_184" STRING="doxazosin gain weight" FREQUENCY=1 START=7726 END=7757 LEMMA="DOXAZOSIN GAIN WEIGHT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_185" STRING="doxazosin unmasking incipient heart failure" FREQUENCY=1 START=17199 END=17250 LEMMA="DOXAZOSIN UNMASKING INCIPIENT HEART FAILURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_186" STRING="endothelin-1" FREQUENCY=1 START=10297 END=10309 LEMMA="ENDOTHELIN-1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_187" STRING="erst" FREQUENCY=1 START=18093 END=18097 LEMMA="ERST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_188" STRING="extracellular fluid volume" FREQUENCY=1 START=4183 END=4209 LEMMA="EXTRACELLULAR FLUID VOLUME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_189" STRING="first-line blood pressure agent" FREQUENCY=1 START=3797 END=3828 LEMMA="FIRST-LINE BLOOD PRESSURE AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_190" STRING="fluid retention" FREQUENCY=1 START=4035 END=4050 LEMMA="FLUID RETENTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_191" STRING="fractional excretion" FREQUENCY=1 START=5130 END=5150 LEMMA="FRACTIONAL EXCRETION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_192" STRING="fractional excretion of sodium" FREQUENCY=1 START=5130 END=5160 LEMMA="SODIUM FRACTIONAL EXCRETION" LEMMA_FREQUENCY=1 HEAD_TERM="fractional excretion" HEAD_LEMMA="FRACTIONAL EXCRETION"
TERM ID="NYU_TERM_193" STRING="harmful effect" FREQUENCY=1 START=896 END=910 LEMMA="HARMFUL EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_194" STRING="harmful effect of doxazosin" FREQUENCY=1 START=896 END=923 LEMMA="DOXAZOSIN HARMFUL EFFECT" LEMMA_FREQUENCY=1 HEAD_TERM="harmful effect" HEAD_LEMMA="HARMFUL EFFECT"
TERM ID="NYU_TERM_195" STRING="heart failure" FREQUENCY=6 START=10108 END=10121 LEMMA="HEART FAILURE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_196" STRING="heart failure" FREQUENCY=6 START=11846 END=11869 LEMMA="HEART FAILURE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_197" STRING="heart failure" FREQUENCY=6 START=12671 END=12684 LEMMA="HEART FAILURE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_198" STRING="heart failure" FREQUENCY=6 START=15647 END=15660 LEMMA="HEART FAILURE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_199" STRING="heart failure" FREQUENCY=6 START=16396 END=16409 LEMMA="HEART FAILURE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_200" STRING="heart failure" FREQUENCY=6 START=17073 END=17094 LEMMA="HEART FAILURE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_201" STRING="heart failure findings" FREQUENCY=1 START=17517 END=17547 LEMMA="HEART FAILURE FINDING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_202" STRING="heart failure occurrences" FREQUENCY=1 START=11903 END=11938 LEMMA="HEART FAILURE OCCURRENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_203" STRING="heat shock protein expression" FREQUENCY=1 START=10606 END=10635 LEMMA="HEAT SHOCK PROTEIN EXPRESSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_204" STRING="histologic evidence" FREQUENCY=1 START=3425 END=3444 LEMMA="HISTOLOGIC EVIDENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_205" STRING="hydrochlorothiazide" FREQUENCY=2 START=5557 END=5576 LEMMA="HYDROCHLOROTHIAZIDE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_206" STRING="hydrochlorothiazide" FREQUENCY=2 START=6432 END=6451 LEMMA="HYDROCHLOROTHIAZIDE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_207" STRING="hypertension therapy" FREQUENCY=1 START=2145 END=2165 LEMMA="HYPERTENSION THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_208" STRING="hypertensive men" FREQUENCY=1 START=4306 END=4322 LEMMA="HYPERTENSIVE MAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_209" STRING="hypertensive patients" FREQUENCY=2 START=8985 END=9006 LEMMA="HYPERTENSIVE PATIENT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_210" STRING="hypertensive patients" FREQUENCY=2 START=10144 END=10165 LEMMA="HYPERTENSIVE PATIENT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_211" STRING="increased plasma" FREQUENCY=1 START=16335 END=16351 LEMMA="INCREASED PLASMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_212" STRING="intensive dietary counseling" FREQUENCY=1 START=8113 END=8151 LEMMA="INTENSIVE DIETARY COUNSELING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_213" STRING="interpretation" FREQUENCY=1 START=11692 END=11706 LEMMA="INTERPRETATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_214" STRING="interstitial fluid volume" FREQUENCY=1 START=4152 END=4177 LEMMA="INTERSTITIAL FLUID VOLUME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_215" STRING="key word" FREQUENCY=1 START=1973 END=1981 LEMMA="KEY WORD" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_216" STRING="key words" FREQUENCY=1 START=1773 END=1782 LEMMA="KEY WORD" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_217" STRING="laboratory changes" FREQUENCY=1 START=4810 END=4828 LEMMA="LABORATORY CHANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_218" STRING="life-prolonging therapy" FREQUENCY=1 START=16467 END=16498 LEMMA="LIFE-PROLONGING THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_219" STRING="line agents" FREQUENCY=1 START=17684 END=17695 LEMMA="LINE AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_220" STRING="line agents for the pharmacologic treatment" FREQUENCY=1 START=17684 END=17735 LEMMA="PHARMACOLOGIC TREATMENT LINE AGENT" LEMMA_FREQUENCY=1 HEAD_TERM="line agents" HEAD_LEMMA="LINE AGENT"
TERM ID="NYU_TERM_221" STRING="lipid profiles" FREQUENCY=1 START=14389 END=14403 LEMMA="LIPID PROFILE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_222" STRING="low-dose" FREQUENCY=1 START=451 END=459 LEMMA="LOW-DOSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_223" STRING="low-dose chlorthalidone" FREQUENCY=2 START=12426 END=12459 LEMMA="LOW-DOSE CHLORTHALIDONE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_224" STRING="low-dose chlorthalidone" FREQUENCY=2 START=13690 END=13723 LEMMA="LOW-DOSE CHLORTHALIDONE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_225" STRING="low-dose chlorthalidone arm" FREQUENCY=1 START=451 END=478 LEMMA="CHLORTHALIDONE ARM LOW-DOSE" LEMMA_FREQUENCY=1 HEAD_TERM="chlorthalidone arm" HEAD_LEMMA="CHLORTHALIDONE ARM"
TERM ID="NYU_TERM_226" STRING="low-dose diuretics" FREQUENCY=3 START=3155 END=3173 LEMMA="LOW-DOSE DIURETIC" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_227" STRING="low-dose diuretics" FREQUENCY=3 START=13035 END=13053 LEMMA="LOW-DOSE DIURETIC" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_228" STRING="low-dose diuretics" FREQUENCY=3 START=17631 END=17649 LEMMA="LOW-DOSE DIURETIC" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_229" STRING="lowering blood pressure" FREQUENCY=1 START=14562 END=14585 LEMMA="LOWERING BLOOD PRESSURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_230" STRING="mL average increase" FREQUENCY=1 START=4401 END=4430 LEMMA="ML AVERAGE INCREASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_231" STRING="mean blood pressure" FREQUENCY=2 START=14787 END=14814 LEMMA="MEAN BLOOD PRESSURE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_232" STRING="mean blood pressure" FREQUENCY=2 START=14852 END=14879 LEMMA="MEAN BLOOD PRESSURE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_233" STRING="mean weight change" FREQUENCY=1 START=6049 END=6077 LEMMA="MEAN WEIGHT CHANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_234" STRING="mmHg" FREQUENCY=1 START=12991 END=12995 LEMMA="MMHG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_235" STRING="mmHg difference" FREQUENCY=1 START=15012 END=15027 LEMMA="MMHG DIFFERENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_236" STRING="mmHg higher" FREQUENCY=1 START=14831 END=14842 LEMMA="MMHG HIGHER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_237" STRING="myocardial damage" FREQUENCY=1 START=9323 END=9340 LEMMA="MYOCARDIAL DAMAGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_238" STRING="myocardial injury" FREQUENCY=1 START=17259 END=17284 LEMMA="MYOCARDIAL INJURY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_239" STRING="myocardium" FREQUENCY=1 START=10639 END=10649 LEMMA="MYOCARDIUM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_240" STRING="myocytes" FREQUENCY=1 START=9852 END=9860 LEMMA="MYOCYTE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_241" STRING="negative effect" FREQUENCY=1 START=14616 END=14631 LEMMA="NEGATIVE EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_242" STRING="neurohormonal changes" FREQUENCY=1 START=15963 END=15992 LEMMA="NEUROHORMONAL CHANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_243" STRING="neurohormonal levels" FREQUENCY=1 START=8659 END=8679 LEMMA="NEUROHORMONAL LEVEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_244" STRING="nonfatal heart failure events" FREQUENCY=1 START=13298 END=13327 LEMMA="NONFATAL HEART FAILURE EVENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_245" STRING="norepinephrine" FREQUENCY=4 START=8934 END=8948 LEMMA="NOREPINEPHRINE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_246" STRING="norepinephrine" FREQUENCY=4 START=9451 END=9465 LEMMA="NOREPINEPHRINE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_247" STRING="norepinephrine" FREQUENCY=4 START=9695 END=9709 LEMMA="NOREPINEPHRINE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_248" STRING="norepinephrine" FREQUENCY=4 START=16186 END=16200 LEMMA="NOREPINEPHRINE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_249" STRING="normotensive patients" FREQUENCY=1 START=8952 END=8983 LEMMA="NORMOTENSIVE PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_250" STRING="original baseline weight" FREQUENCY=1 START=6763 END=6797 LEMMA="ORIGINAL BASELINE WEIGHT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_251" STRING="participants" FREQUENCY=1 START=8388 END=8400 LEMMA="PARTICIPANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_252" STRING="peripheral alpha-1 antagonist" FREQUENCY=2 START=3605 END=3634 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_253" STRING="peripheral alpha-1 antagonist" FREQUENCY=2 START=11218 END=11247 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_254" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=185 END=215 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_255" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=591 END=629 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_256" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=1089 END=1119 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_257" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=1464 END=1494 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_258" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=2692 END=2722 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_259" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=3032 END=3062 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_260" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=8725 END=8755 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_261" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=9961 END=9991 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_262" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=10448 END=10488 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_263" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=11013 END=11053 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_264" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=14355 END=14385 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_265" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=14519 END=14557 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_266" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=15379 END=15409 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_267" STRING="peripheral alpha-1 antagonists" FREQUENCY=14 START=16857 END=16895 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=19
TERM ID="NYU_TERM_268" STRING="peripheral alpha-1 antagonists for lowering blood pressure" FREQUENCY=1 START=14519 END=14585 LEMMA="LOWERING BLOOD PRESSURE PERIPHERAL ALPHA-1 ANTAGONIST" LEMMA_FREQUENCY=1 HEAD_TERM="peripheral alpha-1 antagonists" HEAD_LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST"
TERM ID="NYU_TERM_269" STRING="person-years" FREQUENCY=2 START=13484 END=13496 LEMMA="PERSON-YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_270" STRING="person-years" FREQUENCY=2 START=13659 END=13671 LEMMA="PERSON-YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_271" STRING="perturbations" FREQUENCY=1 START=8632 END=8645 LEMMA="PERTURBATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_272" STRING="pharmacologic treatment" FREQUENCY=1 START=17704 END=17735 LEMMA="PHARMACOLOGIC TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_273" STRING="physiology study" FREQUENCY=1 START=7444 END=7460 LEMMA="PHYSIOLOGY STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_274" STRING="plasma norepinephrine" FREQUENCY=1 START=8801 END=8822 LEMMA="PLASMA NOREPINEPHRINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_275" STRING="plasma volume" FREQUENCY=2 START=4127 END=4140 LEMMA="PLASMA VOLUME" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_276" STRING="plasma volume" FREQUENCY=2 START=4434 END=4447 LEMMA="PLASMA VOLUME" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_277" STRING="plasma volume fluid expansion" FREQUENCY=1 START=7512 END=7541 LEMMA="PLASMA VOLUME FLUID EXPANSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_278" STRING="population differences" FREQUENCY=1 START=8469 END=8491 LEMMA="POPULATION DIFFERENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_279" STRING="positive actions" FREQUENCY=1 START=14678 END=14694 LEMMA="POSITIVE ACTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_280" STRING="positive effects" FREQUENCY=1 START=1069 END=1085 LEMMA="POSITIVE EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_281" STRING="positive effects of peripheral alpha-1 antagonists" FREQUENCY=1 START=1069 END=1119 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST POSITIVE EFFECT" LEMMA_FREQUENCY=1 HEAD_TERM="positive effects" HEAD_LEMMA="POSITIVE EFFECT"
TERM ID="NYU_TERM_282" STRING="potential association" FREQUENCY=1 START=14215 END=14244 LEMMA="POTENTIAL ASSOCIATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_283" STRING="prazosin" FREQUENCY=6 START=1324 END=1332 LEMMA="PRAZOSIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_284" STRING="prazosin" FREQUENCY=6 START=1797 END=1805 LEMMA="PRAZOSIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_285" STRING="prazosin" FREQUENCY=6 START=4068 END=4076 LEMMA="PRAZOSIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_286" STRING="prazosin" FREQUENCY=6 START=4876 END=4884 LEMMA="PRAZOSIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_287" STRING="prazosin" FREQUENCY=6 START=5021 END=5029 LEMMA="PRAZOSIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_288" STRING="prazosin" FREQUENCY=6 START=5578 END=5586 LEMMA="PRAZOSIN" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_289" STRING="prazosin arm" FREQUENCY=1 START=6094 END=6106 LEMMA="PRAZOSIN ARM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_290" STRING="prazosin blocks" FREQUENCY=1 START=10580 END=10595 LEMMA="PRAZOSIN BLOCK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_291" STRING="prazosin blocks heat shock protein expression" FREQUENCY=1 START=10580 END=10635 LEMMA="HEAT SHOCK PROTEIN EXPRESSION PRAZOSIN BLOCK" LEMMA_FREQUENCY=1 HEAD_TERM="heat shock protein expression" HEAD_LEMMA="HEAT SHOCK PROTEIN EXPRESSION"
TERM ID="NYU_TERM_292" STRING="prazosin decreased" FREQUENCY=1 START=6509 END=6537 LEMMA="PRAZOSIN DECREASED" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_293" STRING="primary outcome" FREQUENCY=1 START=12016 END=12031 LEMMA="PRIMARY OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_294" STRING="primary outcome of CHD" FREQUENCY=1 START=12016 END=12038 LEMMA="CORONARY HEART DISEASE PRIMARY OUTCOME" LEMMA_FREQUENCY=1 HEAD_TERM="primary outcome" HEAD_LEMMA="PRIMARY OUTCOME"
TERM ID="NYU_TERM_295" STRING="prostatism" FREQUENCY=2 START=3292 END=3302 LEMMA="PROSTATISM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_296" STRING="prostatism" FREQUENCY=2 START=3373 END=3383 LEMMA="PROSTATISM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_297" STRING="radioisotopic assays" FREQUENCY=1 START=4473 END=4493 LEMMA="RADIOISOTOPIC ASSAY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_298" STRING="ramifications" FREQUENCY=1 START=16031 END=16044 LEMMA="RAMIFICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_299" STRING="randomized trials" FREQUENCY=1 START=7126 END=7143 LEMMA="RANDOMIZED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_300" STRING="rat myocytes" FREQUENCY=1 START=9622 END=9644 LEMMA="RAT MYOCYTE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_301" STRING="recommendations" FREQUENCY=1 START=17608 END=17623 LEMMA="RECOMMENDATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_302" STRING="reference point" FREQUENCY=1 START=12652 END=12667 LEMMA="REFERENCE POINT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_303" STRING="reference point of heart failure" FREQUENCY=1 START=12652 END=12684 LEMMA="HEART FAILURE REFERENCE POINT" LEMMA_FREQUENCY=1 HEAD_TERM="reference point" HEAD_LEMMA="REFERENCE POINT"
TERM ID="NYU_TERM_304" STRING="relative risk" FREQUENCY=1 START=15095 END=15108 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_305" STRING="revealed increases" FREQUENCY=1 START=4105 END=4123 LEMMA="REVEALED INCREASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_306" STRING="risk reduction" FREQUENCY=1 START=13738 END=13752 LEMMA="RISK REDUCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_307" STRING="routine use" FREQUENCY=1 START=2667 END=2688 LEMMA="ROUTINE USE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_308" STRING="routine use of peripheral alpha-1 antagonists" FREQUENCY=1 START=2667 END=2722 LEMMA="PERIPHERAL ALPHA-1 ANTAGONIST ROUTINE USE" LEMMA_FREQUENCY=1 HEAD_TERM="routine use" HEAD_LEMMA="ROUTINE USE"
TERM ID="NYU_TERM_309" STRING="second-line anti-hypertensive therapy" FREQUENCY=1 START=3101 END=3148 LEMMA="SECOND-LINE ANTI-HYPERTENSIVE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_310" STRING="secondary outcome" FREQUENCY=1 START=12056 END=12073 LEMMA="SECONDARY OUTCOME" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_311" STRING="secondary outcome of total mortality" FREQUENCY=1 START=12056 END=12092 LEMMA="TOTAL MORTALITY SECONDARY OUTCOME" LEMMA_FREQUENCY=1 HEAD_TERM="secondary outcome" HEAD_LEMMA="SECONDARY OUTCOME"
TERM ID="NYU_TERM_312" STRING="secondary outcomes" FREQUENCY=1 START=12168 END=12196 LEMMA="SECONDARY OUTCOME" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_313" STRING="sodium" FREQUENCY=1 START=5154 END=5160 LEMMA="SODIUM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_314" STRING="starting point" FREQUENCY=1 START=8511 END=8525 LEMMA="STARTING POINT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_315" STRING="study populations" FREQUENCY=1 START=12709 END=12726 LEMMA="STUDY POPULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_316" STRING="subclinical disease" FREQUENCY=1 START=15675 END=15702 LEMMA="SUBCLINICAL DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_317" STRING="subclinical ventricular dysfunction" FREQUENCY=1 START=17346 END=17381 LEMMA="SUBCLINICAL VENTRICULAR DYSFUNCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_318" STRING="suggesting mechanisms" FREQUENCY=1 START=1608 END=1637 LEMMA="SUGGESTING MECHANISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_319" STRING="symptomatic episodes" FREQUENCY=1 START=17126 END=17146 LEMMA="SYMPTOMATIC EPISODE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_320" STRING="symptoms" FREQUENCY=1 START=3874 END=3882 LEMMA="SYMPTOM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_321" STRING="systolic blood pressure" FREQUENCY=3 START=12891 END=12914 LEMMA="SYSTOLIC BLOOD PRESSURE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_322" STRING="systolic blood pressure" FREQUENCY=3 START=15031 END=15054 LEMMA="SYSTOLIC BLOOD PRESSURE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_323" STRING="systolic blood pressure" FREQUENCY=3 START=15219 END=15242 LEMMA="SYSTOLIC BLOOD PRESSURE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_324" STRING="terazosin" FREQUENCY=4 START=1309 END=1318 LEMMA="TERAZOSIN" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_325" STRING="terazosin" FREQUENCY=4 START=1817 END=1826 LEMMA="TERAZOSIN" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_326" STRING="terazosin" FREQUENCY=4 START=6868 END=6877 LEMMA="TERAZOSIN" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_327" STRING="terazosin" FREQUENCY=4 START=6958 END=6967 LEMMA="TERAZOSIN" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_328" STRING="termination rate" FREQUENCY=2 START=6213 END=6229 LEMMA="TERMINATION RATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_329" STRING="termination rate" FREQUENCY=2 START=6269 END=6285 LEMMA="TERMINATION RATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_330" STRING="tolerability" FREQUENCY=2 START=1190 END=1202 LEMMA="TOLERABILITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_331" STRING="tolerability" FREQUENCY=2 START=11432 END=11444 LEMMA="TOLERABILITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_332" STRING="tolerability trials" FREQUENCY=1 START=6843 END=6862 LEMMA="TOLERABILITY TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_333" STRING="total body sodium" FREQUENCY=2 START=4963 END=4980 LEMMA="TOTAL BODY SODIUM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_334" STRING="total body sodium" FREQUENCY=2 START=5345 END=5362 LEMMA="TOTAL BODY SODIUM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_335" STRING="total mortality" FREQUENCY=1 START=12077 END=12092 LEMMA="TOTAL MORTALITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_336" STRING="treatment groups" FREQUENCY=1 START=8055 END=8071 LEMMA="TREATMENT GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_337" STRING="trial arms" FREQUENCY=1 START=8251 END=8271 LEMMA="TRIAL ARM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_338" STRING="two-week washout period" FREQUENCY=1 START=4640 END=4673 LEMMA="TWO-WEEK WASHOUT PERIOD" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_339" STRING="vascular hormone" FREQUENCY=1 START=10021 END=10037 LEMMA="VASCULAR HORMONE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_340" STRING="ventricular function" FREQUENCY=1 START=17432 END=17452 LEMMA="VENTRICULAR FUNCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_341" STRING="volume expansion" FREQUENCY=3 START=4845 END=4871 LEMMA="VOLUME EXPANSION" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_342" STRING="volume expansion" FREQUENCY=3 START=7414 END=7440 LEMMA="VOLUME EXPANSION" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_343" STRING="volume expansion" FREQUENCY=3 START=15570 END=15586 LEMMA="VOLUME EXPANSION" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_344" STRING="volume expansion for prazosin" FREQUENCY=1 START=4845 END=4884 LEMMA="PRAZOSIN VOLUME EXPANSION" LEMMA_FREQUENCY=1 HEAD_TERM="volume expansion" HEAD_LEMMA="VOLUME EXPANSION"
TERM ID="NYU_TERM_345" STRING="von Willebrand factor" FREQUENCY=1 START=10184 END=10215 LEMMA="VON WILLEBRAND FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_346" STRING="weight change" FREQUENCY=1 START=4688 END=4701 LEMMA="WEIGHT CHANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_347" STRING="weight gain" FREQUENCY=3 START=5754 END=5765 LEMMA="WEIGHT GAIN" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_348" STRING="weight gain" FREQUENCY=3 START=6616 END=6627 LEMMA="WEIGHT GAIN" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_349" STRING="weight gain" FREQUENCY=3 START=8025 END=8036 LEMMA="WEIGHT GAIN" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_350" STRING="weight information" FREQUENCY=1 START=7222 END=7240 LEMMA="WEIGHT INFORMATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_351" STRING="weight loss" FREQUENCY=2 START=6031 END=6042 LEMMA="WEIGHT LOSS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_352" STRING="weight loss" FREQUENCY=2 START=8161 END=8172 LEMMA="WEIGHT LOSS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_353" STRING="withdrawal" FREQUENCY=1 START=7175 END=7185 LEMMA="WITHDRAWAL" LEMMA_FREQUENCY=2
